• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why EMCORE Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

    8/9/23 8:15:36 AM ET
    $AKAN
    $AMRS
    $ASLE
    $ATNF
    Medicinal Chemicals and Botanical Products
    Health Care
    Major Chemicals
    Industrials
    Get the next $AKAN alert in real time by email

    Gainers

    • 180 Life Sciences Corp. (NASDAQ:ATNF) shares surged 109.2% to $1.58 in pre-market trading after falling over 6% on Tuesday.
    • Tango Therapeutics, Inc. (NASDAQ:TNGX) rose 37.1% to $5.25 in pre-market trading after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.
    • Akanda Corp. (NASDAQ:AKAN) shares rose 34.4% to $0.7997 in pre-market trading.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) shares gained 20% to $0.28 in pre-market trading after falling 8% on Tuesday.
    • Amyris, Inc. (NASDAQ:AMRS) rose 19.1% to $0.5382 in pre-market trading after falling 24% on Tuesday.
    • SoundHound AI, Inc. (NASDAQ:SOUN) shares gained 18.1% to $2.35 in pre-market trading after reporting better-than-expected quarterly results.
    • SciSparc Ltd. (NASDAQ:SPRC) gained 17.4% to $0.54 in pre-market trading after gaining over 8% on Tuesday.
    • EMCORE Corporation (NASDAQ:EMKR) shares rose 17.2% to $0.79 in pre-market trading after the company posted better-than-expected quarterly sales.
    • Marqeta, Inc. (NASDAQ:MQ) gained 16.7% to $5.79 in pre-market trading following strong quarterly sales.
    • Loop Media, Inc. (NYSE:LPTV) shares climbed 16.1% to $2.24 in pre-market trading after the company posted upbeat quarterly sales and announced strategic alignment with Microsoft Advertising.

    Losers

    • Bruush Oral Care Inc. (NASDAQ:BRSH) fell 33.1% to $5.15 in pre-market trading after jumping 139% on Tuesday.
    • Doximity, Inc. (NYSE:DOCS) shares fell 24.4% to $24.80 in pre-market trading after the company issued weak sales forecast.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) fell 18.6% to $0.1066 in pre-market trading after jumping over 45% on Tuesday.
    • Inspirato Incorporated (NASDAQ:ISPO) shares fell 18.2% to $0.9801 in pre-market trading after the company reported downbeat second-quarter results and issued weak sales outlook.
    • PubMatic, Inc. (NASDAQ:PUBM) fell 18% to $15.22 in pre-market trading after the company issued weak third-quarter revenue guidance.
    • AerSale Corporation (NASDAQ:ASLE) fell 17.8% to $12.00 in pre-market after the company reported downbeat second-quarter results and issued weak 2023 sales outlook.
    • Upstart Holdings, Inc. (NASDAQ:UPST) fell 17.4% to $42.73 in pre-market trading. Upstart reported better-than-expected results for its second quarter, but issued weak revenue forecast for the third quarter.
    • 2U, Inc. (NASDAQ:TWOU) shares fell 17.1% to $3.55 in pre-market trading following weaker-than-expected quarterly results.
    • Veritone, Inc. (NASDAQ:VERI) fell 17% to $3.32 in pre-market trading after the company posted second-quarter results.
    • Expensify, Inc. (NASDAQ:EXFY) fell 12.2% to $5.20 in pre-market trading after the company reported downbeat results for its second quarter.

     

    Now Read This: Lyft, Disney And 3 Stocks To Watch Heading Into Wednesday

    Get the next $AKAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKAN
    $AMRS
    $ASLE
    $ATNF

    CompanyDatePrice TargetRatingAnalyst
    Doximity Inc.
    $DOCS
    4/20/2026$29.00Buy → Hold
    Truist
    Doximity Inc.
    $DOCS
    4/8/2026$25.00Outperform → In-line
    Evercore ISI
    Tango Therapeutics Inc.
    $TNGX
    4/3/2026$30.00Buy
    Canaccord Genuity
    Tango Therapeutics Inc.
    $TNGX
    4/2/2026$30.00Buy
    Canaccord Genuity
    Upstart Holdings Inc.
    $UPST
    3/16/2026$43.00Neutral → Buy
    BTIG Research
    PubMatic Inc.
    $PUBM
    2/27/2026$10.50Neutral → Buy
    B. Riley Securities
    Tango Therapeutics Inc.
    $TNGX
    2/23/2026$19.00Outperform
    Mizuho
    Upstart Holdings Inc.
    $UPST
    2/17/2026$30.00Sell → Neutral
    Compass Point
    More analyst ratings

    $AKAN
    $AMRS
    $ASLE
    $ATNF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Doximity downgraded by Truist with a new price target

    Truist downgraded Doximity from Buy to Hold and set a new price target of $29.00

    4/20/26 8:23:07 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Doximity from Outperform to In-line and set a new price target of $25.00

    4/8/26 8:28:57 AM ET
    $DOCS
    EDP Services
    Technology

    Canaccord Genuity initiated coverage on Tango Therapeutics with a new price target

    Canaccord Genuity initiated coverage of Tango Therapeutics with a rating of Buy and set a new price target of $30.00

    4/3/26 10:44:59 AM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAN
    $AMRS
    $ASLE
    $ATNF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AerSale® Announces Date for First Quarter 2026 Earnings Release Conference Call

    MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- AerSale Corporation (NASDAQ:ASLE) (the "Company"), announced today that it will release its earnings results for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, after the market closes. The Company will host a conference call on the same day at 4:30 pm Eastern Time to discuss the results. A live audio webcast of the call will be available to the public on a listen‑only basis at https://ir.aersale.com/news-events/events. An archived replay of the webcast will also be available on the Investors portion of the AerSale website at https://ir.aersale.com for one year. About AerSale AerSale is a global provider of integrated aviation

    4/23/26 4:30:00 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026

    Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2026 after market close on May 13, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network membe

    4/23/26 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    Expensify to Announce Q1 2026 Results

    Join Expensify's earnings call on Thursday, May 7th at 2pm PT / 5pm ET. Expensify, Inc. (NASDAQ:EXFY), the easiest way to manage expenses, corporate cards, and travel, today announced that the company's Q1 2026 financial results will be released after market close on Thursday, May 7th, 2026. Expensify will host a call to discuss its Q1 2026 results on Thursday, May 7th, 2026 at 2pm PT / 5pm ET. The link to the call will be available that day on the company's Investor Relations website at investors.expensify.com. Prior to the call, interested parties can visit the website to add the event to their calendars. After the call, the following will be made available at investors.expensify.co

    4/23/26 4:00:00 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    $AKAN
    $AMRS
    $ASLE
    $ATNF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fedder Judith Ann bought $6,464 worth of shares (1,000 units at $6.46), increasing direct ownership by 2% to 62,175 units (SEC Form 4)

    4 - AerSale Corp (0001754170) (Issuer)

    3/16/26 6:55:45 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    Director Linville Judson C bought $100,383 worth of shares (25,570 units at $3.93) (SEC Form 4)

    4 - Marqeta, Inc. (0001522540) (Issuer)

    3/2/26 5:04:55 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKAN
    $AMRS
    $ASLE
    $ATNF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Gall Matthew

    3 - Tango Therapeutics, Inc. (0001819133) (Issuer)

    4/24/26 4:15:03 PM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Newcomb Jessica claimed ownership of 67,321 shares (SEC Form 3)

    3 - Tango Therapeutics, Inc. (0001819133) (Issuer)

    4/24/26 4:15:05 PM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Paul Elaine

    4 - Marqeta, Inc. (0001522540) (Issuer)

    4/22/26 4:58:50 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    $AKAN
    $AMRS
    $ASLE
    $ATNF
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by AerSale Corporation

    SCHEDULE 13G/A - AerSale Corp (0001754170) (Subject)

    4/23/26 3:10:29 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    PubMatic Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - PubMatic, Inc. (0001422930) (Filer)

    4/22/26 5:00:07 PM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology

    SEC Form DEFA14A filed by Marqeta Inc.

    DEFA14A - Marqeta, Inc. (0001522540) (Filer)

    4/21/26 4:13:22 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    $AKAN
    $AMRS
    $ASLE
    $ATNF
    Leadership Updates

    Live Leadership Updates

    View All

    Independent Agencies Gain Advanced Agentic Media Buying Through New PubMatic and Untapped Growth Collective Partnership

    Small and Independent agencies can now activate custom buyer agents within AgenticOS – providing full access to data curation, premium inventory at scale, and GPU-supported infrastructure delivering more efficient and effective performance campaigns PubMatic (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, and Untapped Growth, a multibillion-dollar media buying collective built for independent agencies and mid-market advertisers, today announced a partnership that gives independent agencies direct integration into AgenticOS. Through this collaboration, member agencies in the Untapped Growth collective can now deploy proprietary buyer agents

    3/25/26 9:03:00 AM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology

    Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights

    Initial Phase 1/2 trial data of vopimetostat in combination with Revolution Medicines' RAS(ON) inhibitors in MTAP-deleted pancreatic cancer in 2026 with continued robust patient enrollment New clinical supply agreement with Erasca, plus ongoing Revolution Medicines collaboration, supports potential of vopimetostat as the preferred PRMT5 inhibitor for combination with RAS targeted therapies in oncology Cash position of $343 million as of December 31, 2025, with runway into 2028 beyond anticipated key data inflection points BOSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the n

    3/5/26 7:00:00 AM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    WorkWhile Names Simon Khalaf CEO as Company Enters Next Phase of Growth and Expands Into Worker Financial Services

    Co-Founder Jarah Euston transitions to President and COO; Platform surpasses 1.2 million workers SAN FRANCISCO, Feb. 25, 2026 /PRNewswire/ -- WorkWhile today announced a leadership transition as the company moves into its next phase of growth. Tech veteran and longtime board member Simon Khalaf has been named Chief Executive Officer. Co-Founder Jarah Euston will transition to President and Chief Operating Officer, where she will focus on scaling operations and accelerating expansion. The transition comes at a moment of strength for the company. WorkWhile now serves more than 1.2

    2/25/26 1:24:00 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    $AKAN
    $AMRS
    $ASLE
    $ATNF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Marqeta Inc.

    SC 13G/A - Marqeta, Inc. (0001522540) (Subject)

    11/27/24 8:47:26 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Expensify Inc.

    SC 13G/A - Expensify, Inc. (0001476840) (Subject)

    11/20/24 5:30:35 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Tango Therapeutics Inc.

    SC 13G - Tango Therapeutics, Inc. (0001819133) (Subject)

    11/20/24 4:24:26 PM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAN
    $AMRS
    $ASLE
    $ATNF
    Financials

    Live finance-specific insights

    View All

    AerSale® Announces Date for First Quarter 2026 Earnings Release Conference Call

    MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- AerSale Corporation (NASDAQ:ASLE) (the "Company"), announced today that it will release its earnings results for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, after the market closes. The Company will host a conference call on the same day at 4:30 pm Eastern Time to discuss the results. A live audio webcast of the call will be available to the public on a listen‑only basis at https://ir.aersale.com/news-events/events. An archived replay of the webcast will also be available on the Investors portion of the AerSale website at https://ir.aersale.com for one year. About AerSale AerSale is a global provider of integrated aviation

    4/23/26 4:30:00 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026

    Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2026 after market close on May 13, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network membe

    4/23/26 4:01:00 PM ET
    $DOCS
    EDP Services
    Technology

    Expensify to Announce Q1 2026 Results

    Join Expensify's earnings call on Thursday, May 7th at 2pm PT / 5pm ET. Expensify, Inc. (NASDAQ:EXFY), the easiest way to manage expenses, corporate cards, and travel, today announced that the company's Q1 2026 financial results will be released after market close on Thursday, May 7th, 2026. Expensify will host a call to discuss its Q1 2026 results on Thursday, May 7th, 2026 at 2pm PT / 5pm ET. The link to the call will be available that day on the company's Investor Relations website at investors.expensify.com. Prior to the call, interested parties can visit the website to add the event to their calendars. After the call, the following will be made available at investors.expensify.co

    4/23/26 4:00:00 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology